Clene (CLNN) Construction in Progress (2019 - 2022)
Clene (CLNN) posted Construction in Progress of $6.7 million for Q3 2022, up 37.39% on a QoQ basis from $4.9 million in Q2 2022, and up 529.97% year-over-year from $1.1 million in Q3 2021.
Analysis
Clene (CLNN) Construction in Progress (2019 - 2022) Analysis & Trends
Clene has reported Construction in Progress for 4 years, with the latest figure at $6.7 million in Q3 2022.
- On a quarterly basis, Construction in Progress rose 529.97% year-over-year to $6.7 million in Q3 2022; TTM through Sep 2022 was $6.7 million, a 529.97% increase from a year earlier, with the FY2021 full-year figure at $2.1 million, up 318.78% from the prior year.
- Construction in Progress was $6.7 million for Q3 2022 at Clene, up from $4.9 million in the prior quarter.
- The five-year high for Construction in Progress was $6.7 million in Q3 2022, with the low at $410000.0 in Q4 2019.
- Average Construction in Progress over 4 years is $2.2 million, with a median of $1.1 million recorded in 2021.
- The sharpest annual moves came in 2020 and 2022: Construction in Progress climbed 19.51% in 2020, then soared 529.97% in 2022.
- Over 4 years, Construction in Progress stood at $410000.0 in 2019, then advanced by 19.51% to $490000.0 in 2020, then soared by 318.78% to $2.1 million in 2021, then jumped by 225.73% to $6.7 million in 2022.
- The last three Construction in Progress figures came in at $6.7 million (Q3 2022), $4.9 million (Q2 2022), and $3.0 million (Q1 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | - |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 6.68 Mn |
| Jun 30, 2022 | 4.87 Mn |
| Mar 31, 2022 | 2.96 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 1.06 Mn |
| Jun 30, 2021 | 821,000.00 |
| Mar 31, 2021 | 663,000.00 |
| Dec 31, 2020 | 490,000.00 |
| Dec 31, 2019 | 410,000.00 |